OncoCyte Ownership | Who Owns OncoCyte?


OverviewForecastRevenueFinancialsChartTranscripts

OncoCyte Ownership Summary


OncoCyte is owned by 0.17% institutional investors, 22.03% insiders, and 77.79% retail investors. Awm investment company is the largest institutional shareholder, holding 0% of OCX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.66% of its assets in OncoCyte shares.

OCX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOncoCyte0.17%22.03%77.79%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryBiotech Stocks 63.94%10.67%25.38%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Awm investment company---
Defender capital, llc.---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Awm investment company---
Defender capital, llc.---

Top Buyers

HolderShares% AssetsChange
Defender capital, llc.---44.38K
Awm investment company---1.10M

Top Sellers

HolderShares% AssetsChange
Awm investment company---1.10M
Defender capital, llc.---44.38K

Sold Out

HolderChange
Defender capital, llc.-44.38K
Awm investment company-1.10M

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-44,378-5.74%-146.55%--1-
Dec 31, 20241-47,078-20.68%-183.27%--100.00%1-
Sep 30, 20241-50.00%59,353-94.85%-0.22%1---100.00%
Jun 30, 20242-1,152,39542.24%1312.44%1-1-
Mar 31, 20242-810,171-1.91%1010.58%--100.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv189.73K0.66%4.14K
Vanguard US Total Market Shares ETF154.88K0.54%-
Vanguard Institutional Extnd Mkt Idx Tr121.17K0.42%324.00
Fidelity Extended Market Index81.28K0.28%-364.00
Fidelity Total Market Index25.25K0.09%-
iShares Micro-Cap ETF24.17K0.08%-
Fidelity Series Total Market Index21.09K0.07%-
BlackRock Extended Equity Market K9.28K0.07%-4.00
NT Ext Equity Mkt Idx Fd - L17.49K0.06%-
Northern Trust Extended Eq Market Idx17.49K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 07, 2025James Andrea S. Chief Financial OfficerBuy$200.00K
Feb 07, 2025SMITH PATRICK W-Buy$2.21M
Feb 06, 2025BROADWOOD PARTNERS, L.P.-Buy-
Feb 06, 2025BROADWOOD PARTNERS, L.P.-Buy-
Feb 06, 2025BROADWOOD PARTNERS, L.P.-Buy$9.24M

Insider Transactions Trends


DateBuySell
2025 Q113-
2024 Q46-
2024 Q3--
2024 Q24-
2023 Q4--

OCX Ownership FAQ


Who Owns OncoCyte?

OncoCyte shareholders are primarily institutional investors at 0.17%, followed by 22.03% insiders and 77.80% retail investors. The average institutional ownership in OncoCyte's industry, Biotech Stocks , is 63.94%, which OncoCyte falls below.

Does Blackrock own OncoCyte?

BlackRock is not among the top 10 institutional shareholders of OncoCyte.

Who is OncoCyte’s biggest shareholder by percentage of total assets invested?

Awm investment company is OncoCyte’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 OncoCyte shares, valued at 0$.

Who is the top mutual fund holder of OncoCyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of OncoCyte shares, with 0.66% of its total shares outstanding invested in 189.73K OncoCyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools